Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Mustang Bio (MBIO) Tops Q1 EPS by 2c
May 10, 2019 7:40 AM EDTMustang Bio (NASDAQ: MBIO) reported Q1 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).
As of March 31, 2019, Mustangs consolidated cash, cash equivalents, short-term investments (certificates of deposit) and restricted cash totaled $41.1 million, compared to $34.6 million as of December 31, 2018, an increase of $6.5 million for the quarter.Research and development expenses were $7.0 million for the first quarter of 2019, compared to $4.3 million for the first quarter of 2018. Non-cash, stock-based compensation expenses included in research and development were $0.1 million for first quarter of 2019, compared to $1.5 million for the first quarter of 2018.Research and development... MoreFortress Biotech (FBIO) Tops Q1 EPS by 60c, Slight Beat on Revenues
May 10, 2019 7:39 AM EDTFortress Biotech (NASDAQ: FBIO) reported Q1 EPS of $0.02, $0.60 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $6.48 million versus the consensus estimate of $6.41 million.
As of March 31, 2019, Fortress consolidated cash, cash equivalents, short-term investments (certificates of deposit), and restricted cash totaled $137.5 million, compared to $99.2 million as of December 31, 2018, an increase of $38.3 million for the quarter.Fortress net revenue totaled $6.5 million for the first quarter of 2019, compared to $5.9 million for the first quarter of 2018.Research and development expenses were $23.3 million for the first quarter of 2019, of which $22.6 million... More